Highside Capital Management
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 15, 2021
Mythic Therapeutics
|
Series B | $103M | Biotechnology | — |
Aug 2, 2021
InterVenn
|
Series C | $201M | Biotechnology | — |